Company Profile

Veralox Therapeutics Inc
Profile last edited on: 9/28/21      CAGE: 7ZJJ7      UEI: RFBNMJDWPTJ7

Business Identifier: Small molecule therapeutics treating underlying pathologies of thrombosis and Type One diabetes
Year Founded
2017
First Award
2018
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4539 Metropolitan Court
Frederick, MD 21704
   (301) 360-3502
   N/A
   www.veraloxtx.com
Location: Single
Congr. District: 06
County: Frederick

Public Profile

Located in the Frederick Innovative Technology Center, Inc., Veralox Therapeutics Inc is a small molecule drug discovery and development firm working on development of a first-in-class therapeutic targeting rare immune-mediated blood disorders. The effort is initially focused around heparin-induced thrombocytopenia (HIT) and HIT with thrombosis (HITT) both life-threatening diseases have a high mortality rate with limb amputations often required due to complications. Second generation therapeutic products are under development for type 1 diabetes (T1D) as well as other immune-mediated and inflammatory diseases.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $300,000
Project Title: Novel Therapeutic for Treatment of Type 1 Diabetes
2018 1 NIH $319,133
Project Title: Development of a 12-Lox Inhibitor for Heparin Induced Thrombocytopenia and Thrombosis

Key People / Management

  Jeffrey Strovel -- Chief Executive Officer

  Matthew Boxer -- Co-Founder and COO

  Michael Hanna -- Chief Medical Office

  Michael Holinstat -- Co-Founder and Chief Executive Officer

  David Joseph Maloney -- Co-Founder and Chief Strategy Officer

Company News

There are no news available.